Arix Pegs LogicBio's Technology As 'Occam's Razor' Of Gene Therapy

Gene therapy startup LogicBio, with input from Arix Biosciences, has raised almost $50m via a series B financing round; it plans to use the cash to continue development of a potential novel alternative to traditional gene therapy.